by Team Small News | Oct 12, 2025 | Lupin, Pharma
Lupin, a pharmaceutical company, has received one observation from the US Food and Drug Administration (USFDA) for its facility located in Somerset, New Jersey. The USFDA observation is a result of an inspection conducted by the regulatory agency, which identified a... by Team Small News | Oct 9, 2025 | Lupin, Pharma
Lupin Pharmaceuticals, a global pharmaceutical company, has announced plans to build a $250 million manufacturing plant in Coral Springs, Florida. The new facility is expected to create approximately 200 jobs in the area, providing a significant boost to the local... by Team Small News | Oct 5, 2025 | Lupin, Pharma
Lupin, a pharmaceutical company, has recently received the USFDA OAI (Official Action Indicated) status for its Pithampur Unit 2 facility. The USFDA (United States Food and Drug Administration) is responsible for ensuring the safety and efficacy of drugs and medical... by Team Small News | Oct 2, 2025 | Lupin, Pharma
Lupin, a pharmaceutical company, has announced the retirement of its Manufacturing Operations President, Rajendra Chunodkar. As a key member of the company’s leadership team, Chunodkar has played a crucial role in overseeing the manufacturing operations of the... by Team Small News | Sep 30, 2025 | Lupin, Pharma
Lupin, a global pharmaceutical company, has recently announced a significant deal with VISUfarma, a European-based ophthalmic company, worth €190 million. This acquisition is expected to play a crucial role in Lupin’s strategy to de-risk its US business and...
by Team Small News | Sep 29, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma, Sun Pharma
The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant...